Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease

• Dineo Mpanya,
• Mike Sathekge,
• Mike Sathekge,
• Eric Klug,
• Eric Klug,
• Jenna Damelin,
• Stuart More,
• Bawinile Hadebe,
• Bawinile Hadebe,
• Mariza Vorster,
• Mariza Vorster,
• Nqoba Tsabedze

Affiliations

Dineo Mpanya

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Mike Sathekge

Department of Nuclear Medicine, University of Pretoria, Pretoria, Gauteng, South Africa

Mike Sathekge

Nuclear Medicine Research Infrastructure, Steve Biko Academic Hospital, Pretoria, South Africa

Eric Klug

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Eric Klug

Netcare Sunninghill, Sunward Park Hospitals, Johannesburg, South Africa

Jenna Damelin

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Stuart More

Division of Nuclear Medicine, Department of Radiation Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Bawinile Hadebe

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa

Bawinile Hadebe

Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital, Durban, South Africa

Mariza Vorster

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa

Mariza Vorster

Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital, Durban, South Africa

Nqoba Tsabedze

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa